Latest Regulatory News

Unith Ltd has acknowledged a technical breach of its trading policy following a director's share purchase during a closed period, prompting a comprehensive review of its governance framework.

Papyrus Australia Ltd has announced a $262,000 capital raise through a share placement and unlisted options, aiming to strengthen its working capital and research efforts.

Syntara Limited’s trading suspension has been lifted as the company lodged its quarterly activity and cash flow reports for June 2025, reopening its shares to market activity.

X2M Connect Limited’s X2MO securities have been suspended from ASX trading due to non-compliance with listing rules, raising questions about the company’s regulatory standing and next steps.

Domain Holdings Australia announces a special fully franked dividend of 8.8 cents per share, contingent on shareholder and court approval of its acquisition by CoStar Group.

Rhythm Biosciences has advanced its ColoSTAT® diagnostic kits to final production validation, demonstrating consistent detection of colorectal cancer across all stages in a pivotal study. The company is gearing up for regulatory submission and commercial launch later this year.

InVert Graphite reports robust trench assay results from its Kumba deposit in Tanzania, revealing consistent high-grade graphite mineralisation over a 2km strike. The company is advancing drilling preparations amid a significant US move to impose anti-dumping duties on Chinese graphite imports.

Domain Holdings Australia has announced a fully franked special dividend alongside a recommended $4.43 per share acquisition offer from CoStar Group, pending shareholder and court approval.

Nyrada Inc. has raised $8.25 million through a strategic placement to fund its upcoming Phase IIa clinical trial of Xolatryp for acute myocardial infarction, positioning the company for a pivotal year ahead.

Antilles Gold Limited has had its trading suspension lifted on the ASX following the release of its quarterly activity and cash flow reports for June 2025, reopening the stock to market activity.

Medallion Metals has executed a binding agreement to acquire the Forrestania Nickel Operation from IGO Limited, setting the stage for a low-capital pathway to gold and copper production at its Ravensthorpe project. The transaction targets completion and a final investment decision by late 2025.

Osteopore Limited has won tender bids to supply its innovative orthopaedic implants to two major public hospitals in Vietnam, marking a significant step in its Asia Pacific expansion.